Please be aware that this is a machine translation from French to English. AVICENN is not responsible for incorrect or inaccurate translations but welcomes suggestions for reformulation.

VeilleNanos - Nanomedicine: promises and risks

Nanomedicine: promises and risks

image
cards
News
Agenda

Nanomedicine, transhumanism and NBIC in the medical field: promises and risks

By AVICENN – Last updated May 2025

The acronym NBIC refers to the convergence of nanotechnologies (N) with biotechnologies (B), information sciences (I), and cognitive sciences (C).

Some quotes as a preamble:

“In the utopian hope of being able to conquer death and suffering through the limitless power of our science, all of us, doctors, patients, health authorities, politicians… get drunk on the uninterrupted flow of discoveries that biotechs like to announce with great fanfare. Drunkenness sometimes leads to absurdity (…). This leads to a real problem ofhealth equity: all other things being equal, patients who can benefit from sophisticated treatments will receive more resources from the national solidarity than those requiring “human” care, considered less prestigious. – Bruno Falissard, “ Medicine is the best alibi for technoscientific hubris “, Le Monde, September 2022.

“In the 1960s, during the presidency of Richard Nixon, the U.S. administration had decreed a “war on cancer.” The promise was that “in 10 years, we will have won”. Lots and lots of money was spent. Not everything has been in vain, but this war has obviously not been won”. – Jean-Marc Lévy-Leblond, “There is no democratic control of science,” Critical Science, December 2015.

“New curative advances still allow those without excellent intrinsic longevity to nibble away a few years of life after age 65. However, these results are nothing compared to the preventive measures known as hygienic-dietary rules. These can be summarized as three: regular walking, caloric restriction and smoking cessation. Their results are far superior to any pharmacological or instrumental interventions in most neurodegenerative, tumor, cardiovascular, infectious and locomotor pathologies“. – Luc Perino, excerpt from “Refusing death can be deadly,” in For Health Reasons – Medicine and the Facts, July 8, 2015.

Promises of nanomedicine and NBICs in the medical field

General or synthetic documents on nanomedicine

In French :

In English:

More "specialized" or focused documents

In French :

→ English:

Risks, regulation and societal issues raised by nanomedicine, transhumanism and NBIC in the medical field

Explore the bibliography

English:

Any questions or comments? This information sheet compiled by AVICENN is intended to be completed and updated. Please feel free to contribute.

Upcoming Nano Agenda

1
Juin
2025
Controlling the risks associated with nanomaterials (CEA, Online)
On line
Training
  • E-learning program: awareness-raising for personnel who come into contact with nanomaterials during research, formulation, production, maintenance, cleaning, upkeep, etc., as well as safety coordinators or engineers, facility managers, heads of laboratories where nanoparticles are handled.
  • Organizers: INSTN Grenoble (CEA)
  • On the program:
    • 1 – Introduction, definition and characteristics of nanomaterials
    • 2 – Toxicity of nanomaterials: the state of knowledge
    • 3 – Metrology and characterization of nanomaterials
    • 4 – Prevention and protection against nanomaterials in the workplace
    • 5 – Quiz: assessment of learning outcomes
  • The 2-hour course can be viewed for one month from the date of registration.
  • Website: https://instn.cea.fr/…risques-lies-aux-nanomateriaux…
1
Juin
2025
Applications of Nanomaterials to Sustainably Address Water, Food, and Health (Newry, Maine – United States)
Newry, Maine
Conference
11
Juin
2025
Risk assessment of nanomaterials and materials containing small/nanoparticles in the food and feed chain (EFSA, Brussels & online)
On line
Workshop
additives
food
characterization
detection
  • Workshop on risk assessment of nanomaterials and materials containing small/nanoparticles in the food and feed chain
  • Organizer: EFSA
  • This workshop will present the proposed strategy for updating the EFSA Nano Guidance documents, aiming to merge them into a single guidance on risk assessment for nanomaterials and small/nanoparticles in the food and feed chain.
    The event will provide an open platform for discussing key issues, approaches to addressing them, and ensuring the guidance reflects the latest scientific knowledge. Stakeholders will be encouraged to share experiences and engage with regulators, helping shape the updated guidance.
  • Website: www.efsa.europa.eu/en/events/workshop-risk-assessment-nanomaterials-and-materials-containing-smallnanoparticles-food-and

This sheet was originally created in February 2019


Our monitoring, information and actions need you to continue !